Neurocrine director Leslie V. Norwalk sells 1,250 shares for $227,507.5 - NBIX News | RalliesNeurocrine director Leslie V. Norwalk sells 1,250 shares for $227,507.5
N
NBIX• Director share sale and option exercise
- Neurocrine Biosciences director Leslie V. Norwalk sold 1,250 shares on July 28 at a weighted average price of USD 182.01.
- Norwalk exercised a non-qualified stock option for 842 shares on July 29 at USD 139.43.
- She reported 2,430 shares owned following the transactions.
- She also reported 2,140 non-qualified stock options outstanding following the transactions.
•
